These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30628963)

  • 1. A heterozygous mutation in GJA1 gene in Chinese family with serious erythrokeratodermia variabilis et progressive.
    Guo BR; Cai HB; Zong WK; Li CS; Liu LZ; Qiao S; Zhu QM; Li M
    Chin Med J (Engl); 2019 Jan; 132(1):86-88. PubMed ID: 30628963
    [No Abstract]   [Full Text] [Related]  

  • 2. Two de novo GJA1 mutation in two sporadic patients with erythrokeratodermia variabilis et progressiva.
    Li C; Liang J; Chen P; Zeng K; Xue R; Tian X; Liang L; Wang Q; Shi M; Zhang X
    Mol Genet Genomic Med; 2019 Jun; 7(6):e670. PubMed ID: 30924322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Linear Verrucous Epidermal Nevus with a Postzygotic GJA1 Mutation Is a Mosaic Erythrokeratodermia Variabilis et Progressiva.
    Umegaki-Arao N; Sasaki T; Fujita H; Aoki S; Kameyama K; Amagai M; Seishima M; Kubo A
    J Invest Dermatol; 2017 Apr; 137(4):967-970. PubMed ID: 27890787
    [No Abstract]   [Full Text] [Related]  

  • 4. The novel GJB3 mutation p.Thr202Asn in the M4 transmembrane domain underlies erythrokeratodermia variabilis.
    Sugiura K; Arima M; Matsunaga K; Akiyama M
    Br J Dermatol; 2015 Jul; 173(1):309-11. PubMed ID: 25556823
    [No Abstract]   [Full Text] [Related]  

  • 5. Dominant De Novo Mutations in GJA1 Cause Erythrokeratodermia Variabilis et Progressiva, without Features of Oculodentodigital Dysplasia.
    Boyden LM; Craiglow BG; Zhou J; Hu R; Loring EC; Morel KD; Lauren CT; Lifton RP; Bilguvar K; Paller AS; Choate KA
    J Invest Dermatol; 2015 Jun; 135(6):1540-1547. PubMed ID: 25398053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrokeratodermia variabilis et progressiva allelic to oculo-dento-digital dysplasia.
    Duchatelet S; Hovnanian A
    J Invest Dermatol; 2015 Jun; 135(6):1475-1478. PubMed ID: 25964267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fulminant myocarditis following recurrent generalized erythrokeratoderma in a child with a heterozygous GJA1 variant.
    Kobayashi H; Shiohama T; Nakashima M; Saitsu H; Suga Y; Ebata R; Shimojo N
    Am J Med Genet A; 2020 Aug; 182(8):1933-1938. PubMed ID: 32449269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrogation of Carboxy-Terminus Localized
    Lucaciu SA; Shao Q; Figliuzzi R; Barr K; Bai D; Laird DW
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrokeratoderma Variabilis Caused by p.Gly45Glu in Connexin 31: Importance of the First Extracellular Loop Glycine Residue for Gap Junction Function.
    Takeichi T; Sugiura K; Hsu CK; Nomura T; Takama H; Simpson MA; Shimizu H; McGrath JA; Akiyama M
    Acta Derm Venereol; 2016 May; 96(4):557-9. PubMed ID: 26632638
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythrokeratoderma variabilis caused by a recessive mutation in GJB3.
    Fuchs-Telem D; Pessach Y; Mevorah B; Shirazi I; Sarig O; Sprecher E
    Clin Exp Dermatol; 2011 Jun; 36(4):406-11. PubMed ID: 21564177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome sequencing identifies novel compound heterozygous mutations in GJB3 gene that cause erythrokeratodermia variabilis et progressiva.
    Deng Y; Wang H; Mou Y; Zeng Q; Xiong X
    Australas J Dermatol; 2019 Feb; 60(1):e87-e89. PubMed ID: 29992552
    [No Abstract]   [Full Text] [Related]  

  • 12. A missense mutation in the GJB3 gene responsible for erythrokeratodermia variabilis in a Chinese family.
    Wang W; Liu LH; Chen G; Gao M; Zhu J; Zhou FS; Cheng H; Tang HY; Wu BY; Sun LD; Yang S; Wang PG; Zhang XJ
    Clin Exp Dermatol; 2012 Dec; 37(8):919-21. PubMed ID: 22681493
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythrokeratodermia variabilis et progressiva due to a novel mutation in GJB4.
    Zhang X; Xu P; Lu J; Ding Y; Gu J; Shi Y
    Exp Dermatol; 2022 Apr; 31(4):594-599. PubMed ID: 34717022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mutation in GJB4 gene (connexin 30.3) in a family with erythrokeratodermia variabilis.
    Sbidian E; Bousseloua N; Jonard L; Leclerc-Mercier S; Bodemer C; Hadj-Rabia S
    Acta Derm Venereol; 2013 Mar; 93(2):193-5. PubMed ID: 23037955
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutation analysis of GJB3 and GJB4 in Chinese patients with erythrokeratodermia variabilis.
    Liu H; Liu H; Fu XA; Yu YX; Zhou GZ; Lu XM; Tian HQ; Yu CP; Shi ZX; Yu ML; Zhang FR
    J Dermatol; 2012 Apr; 39(4):400-1. PubMed ID: 21950330
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel GJB3 (Cx31) missense mutation in a Chinese patient with erythrokeratodermia variabilis.
    Wang ZX; Lu WS; Li H; Lin D; Zhou FS; Sun LD; Yang S; Zhang XJ
    J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):113-5. PubMed ID: 20497287
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel and recurrent mutations in GJB3 and GJB4 cause erythrokeratodermia variabilis et progressiva.
    Dai S; Wang H; Lin Z
    Indian J Dermatol Venereol Leprol; 2020; 86(1):87-90. PubMed ID: 31793497
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel and recurrent connexin 30.3 and connexin 31 mutations associated with erythrokeratoderma variabilis.
    Scott CA; O'Toole EA; Mohungoo MJ; Messenger A; Kelsell DP
    Clin Exp Dermatol; 2011 Jan; 36(1):88-90. PubMed ID: 21188847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual missense mutation in the GJB3 gene resulting in severe erythrokeratodermia variabilis.
    Glatz M; van Steensel MA; van Geel M; Steijlen PM; Wolf P
    Acta Derm Venereol; 2011 Oct; 91(6):714-5. PubMed ID: 21879244
    [No Abstract]   [Full Text] [Related]  

  • 20. Expanding the clinical phenotype associated with ELOVL4 mutation: study of a large French-Canadian family with autosomal dominant spinocerebellar ataxia and erythrokeratodermia.
    Cadieux-Dion M; Turcotte-Gauthier M; Noreau A; Martin C; Meloche C; Gravel M; Drouin CA; Rouleau GA; Nguyen DK; Cossette P
    JAMA Neurol; 2014 Apr; 71(4):470-5. PubMed ID: 24566826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.